Webcast: Pills and CEOs Under Fire as M&A Fades
The Deal and its expert panel discuss increased scrutiny on executive pay, poison pills and other measures taken to defend against activist campaigns.
Activism
Stay ahead of the trends with breaking and in-depth coverage of the latest activist campaigns, companies ripe for change and the people driving that change.
Activism Intelligence
News From The Deal
Drinks With The Deal: Dechert's Ken Young
Dechert's Ken Young discusses how PE firms have diversified, the challenges of partner development and his recent deals.
Webcast: SPACs are Back
The Deal and its panel of experts discuss the proliferation of SPACs in the IPO market and whether this trend will continue as the economy rebounds.
